The IL3 Knockout AGS Polyclonal Cells product comprises a CRISPR/Cas9-edited polyclonal population of AGS human gastric epithelial cells, engineered to disrupt the interleukin-3 (IL3) gene. This polyclonal knockout model provides a loss-of-function system for investigating IL3-dependent signaling mechanisms within a gastric adenocarcinoma context. The heterogeneous nature of the polyclonal population captures a spectrum of editing outcomes while maintaining robust IL3 deficiency across the culture, offering a physiologically relevant system for functional genomics studies.
The AGS cell line originates from a human gastric adenocarcinoma and serves as a widely accepted in vitro model of gastric epithelium. These cells contribute to studies of gastric mucosal barrier function, acid and enzyme secretion, and the molecular pathology of gastric carcinogenesis. The AGS host background expresses key epithelial markers and retains signaling networks responsive to cytokines and growth factors, making it suitable for analyzing the interplay between IL3-mediated pathways and gastric cell biology.
IL3 functions as a pleiotropic cytokine that regulates hematopoiesis and immune cell activity, with emerging roles in non-hematopoietic contexts. Mechanistically, IL3 binds to a heterodimeric receptor composed of IL3RA and CSF2RB, triggering activation of JAK2. JAK2 subsequently phosphorylates STAT5, which translocates to the nucleus and promotes expression of target genes including BCL2L1, CCND1, and MYC. Concurrently, JAK2 initiates the MAPK cascade through RAF1 and MAPK3, and the PI3K-AKT pathway via AKT1, collectively driving cell proliferation, survival, and migration. Upstream regulators such as NFAT and AP-1 transcription factors, along with inflammatory stimuli like IL1B and TNF, modulate IL3 expression.
In gastric epithelial cells, IL3 signaling intersects with pathways frequently dysregulated in gastric cancer, including JAK-STAT, MAPK, and PI3K-AKT. This knockout model enables dissection of IL3-specific contributions to tumor cell-intrinsic processes and may reveal paracrine or autocrine loops within the tumor microenvironment. Given IL3’s roles in inflammation and immune regulation, these polyclonal knockout cells are pertinent for studying gastric cancer-associated inflammation and potential cross-talk between epithelial and immune compartments.
Researchers can employ these knockout cells in diverse experimental workflows. Western blotting and RT-qPCR allow confirmation of IL3 ablation and assessment of downstream target expression. Functional assays such as MTS proliferation, Annexin V apoptosis detection, and wound healing migration assays quantify phenotypic consequences of IL3 loss. Phospho-STAT5 flow cytometry provides a direct readout of pathway activity, facilitating drug target validation and cytokine signaling dissection. By integrating these approaches, scientists can explore IL3-dependent mechanisms in gastric cancer progression, therapeutic resistance, and the broader tumor microenvironment. For further technical details and availability, please contact Ascent Research.
